Some comments made by the staff of the FDA in a report released Tuesday has investors betting that GW Pharmaceuticals (GWPH) will receive regulatory approval for a drug derived from marijuana.
from RTT - Before the Bell https://ift.tt/2vkk6Om
via IFTTT
No comments:
Post a Comment